Your browser doesn't support javascript.
loading
Strategic treatment optimization for HCV (STOPHCV1): a randomised controlled trial of ultrashort duration therapy for chronic hepatitis C.
Cooke, Graham S; Pett, Sarah; McCabe, Leanne; Jones, Chris; Gilson, Richard; Verma, Sumita; Ryder, Stephen D; Collier, Jane D; Barclay, Stephen T; Ala, Aftab; Bhagani, Sanjay; Nelson, Mark; Ch'Ng, Chinlye; Stone, Ben; Wiselka, Martin; Forton, Daniel; McPherson, Stuart; Halford, Rachel; Nguyen, Dung; Smith, David; Ansari, Azim; Dennis, Emily; Hudson, Fleur; Barnes, Eleanor J; Walker, Ann Sarah.
Afiliação
  • Cooke GS; Department of Infectious Disease, Imperial College London, London, W2 1NY, UK.
  • Pett S; NIHR Biomedical Research Centre, Imperial College NHS Trust, London, W2 1NY, UK.
  • McCabe L; MRC Clinical Trials Unit, University College London Medical School, London, UK.
  • Jones C; Mortimer Market Centre, Central and North West London NHS Foundation Trust, London, UK.
  • Gilson R; Institute of Global Health, University College London Medical School, London, UK.
  • Verma S; MRC Clinical Trials Unit, University College London Medical School, London, UK.
  • Ryder SD; Department of Infectious Disease, Imperial College London, London, W2 1NY, UK.
  • Collier JD; NIHR Biomedical Research Centre, Imperial College NHS Trust, London, W2 1NY, UK.
  • Barclay ST; Mortimer Market Centre, Central and North West London NHS Foundation Trust, London, UK.
  • Ala A; Institute of Global Health, University College London Medical School, London, UK.
  • Bhagani S; Hepatology, Brighton and Sussex Medical School, Brighton, UK.
  • Nelson M; Hepatology, Nottingham University Hospitals NHS Trust, Nottingham, UK.
  • Ch'Ng C; Hepatology, John Radcliffe Hospital, Oxford, UK.
  • Stone B; Gastroenterology, Glasgow Royal Infirmary, Glasgow, UK.
  • Wiselka M; Clinical and Experimental Medicine, University of Surrey, Guilford, UK.
  • Forton D; Infectious Diseases, Royal Free Hampstead NHS Trust Hospital, London, UK.
  • McPherson S; HIV Medicine, Chelsea & Westminster NHS Trust, London, UK.
  • Halford R; Swansea Bay University Health Board, Swansea, UK.
  • Nguyen D; Infectious Diseases, Sheffield Teaching Hospitals Nhs Foundation Trust, Sheffield, UK.
  • Smith D; Infectious Diseases, University Hospitals of Leicester NHS Trust, Leicester, UK.
  • Ansari A; Hepatology, St George's Hospital, London, London, UK.
  • Dennis E; Heaptology, Newcastle Upon Tyne Hospitals NHS Trust, Newcastle, UK.
  • Hudson F; Hepatitis C Trust, London, UK.
  • Barnes EJ; Peter Medawar Buildling for Pathogen Research, Oxford, UK.
  • Walker AS; Peter Medawar Buildling for Pathogen Research, Oxford, UK.
Wellcome Open Res ; 6: 93, 2021.
Article em En | MEDLINE | ID: mdl-34405118
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies Idioma: En Revista: Wellcome Open Res Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies Idioma: En Revista: Wellcome Open Res Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido